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Grena ray is a form of "soft" ionizing radiation
which, in contrast to conventional x-ray, has
been considered relatively safe and free from
injurious side effects. When late radiation
sequelae have been reported there has been
reason to suspect that an unusually high dosage
of grenz ray had been unintentionally given
because of a mistake or improper calibration, or
that the radiation given was actually outside of
the grenz ray range. Although radiodermatitis
has followed grenz ray administration, only one
case of squamous cell carcinoma has been re-
ported following grenz ray exposure. This case
was in a physician who had been exposed to
dosages known to be outside of the therapeutic
range over a fifteen-year period (1).
Grenz rays are produced by an x-ray machine
at a kilovoltage of eight to fifteen KV and have
a half value layer of .018 to .036 millimeters of
aluminum. These x-ray machines have a beryl-
lium window which allows passage of the longer
wave lengths. This quality of radiation lies be-
tween conventional x-ray and ultraviolet in the
electromagnetic spectrum. Thus it may be ex-
pected that the biological effects might have
certain properties in common with both conven-
tional x-ray and ultraviolet wave lengths.
The present study was initiated with a two-
fold purpose. The primary purpose was to
ascertain the effects on living tissue of grenz ray,
given in low dosage over a prolonged period of
time. Secondly, the study was designed to deter-
mine whether or not drugs which seem to alter
the effects of radiant energy in the ultraviolet
range might also modify electromagnetic wave
lengths of slightly greater energy.
In a previous experiment it was shown that
approximately one-half of the albino mice
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treated with mid-ultraviolet light for fifteen
minutes a day at fifty centimeters distance from
the light source would show damage and that
about one-fourth of the animals would develop
skin cancers on the ears and face after five
months (2). In other studies the antimalarial
drugs, chioroquine and Triquin, were found to
provide some protection against erythema and
carcinogenesis (3). Another drug, 8-methoxy-
psoralen (8-MP), when fed to albino mice in
their diet was found by O'Neal and Griffin to
offer slight protection against the cutaneous
carcinogenetic effect of ultraviolet light (4).
8-methoxypsoralen has also been shown to
increase ultraviolet carcinogenesis when injected
intraperitoneally and to activate the normally
harmless longer ultraviolet wavelengths (5, 6).
The lethal dose of conventional x-ray for 50%
of mice in thirty days (LD 50) has been deter-
mined to be between 400 to 600 when given as
total-body radiation (7). In other experiments it
was determined that the LD 100 for our strain of
albino mice was 625 r (H.V.L. 2 millimeters Cu.)
(8). No references could be found with regard to
the effect of grenz ray on mice. In humans it has
been shown that changes such as telangiectasia,
hyperpigmentation and atrophy have appeared
after as little as 3,720 r of grenz radiation given
in a single dose (9, 10, 11).
METHOD
A group of 100 Swiss strain female albino mice
were divided into 10 groups of 10 mice each for
study of the chronic effects of grenz ray irradi-
ation. The irradiation was obtained from a Uni-
versal Grenz ray machine utilizing factors of 12
Ky, 10 MA, H.V.L. .025, and a distance from the
target of 25 centimeters. Irradiation of the mice
was started on April 6, 1959, at the rate of 50 r
per day except Sundays and holidays. Irradiation
was administered to the animals while they re-
mained in their wire mesh cages.
The absolute control animals (Groups No. 1
and 2) were fed regular laboratory chow and
f Triquin = chioroquine disphosphate, quin-
acrine hydrochloride, and hydroxychloroquine.
Winthrop Laboratories, New York, N. Y.
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were not irradiated. The radiation control animals
(Groups No. 3 and 4) were also fed laboratory
chow and were irradiated as described. The re-
maining groups of animals were irradiated in an
identical manner but received special diets.
Groups 5 and 6 were fed pulverized laboratory
chow containing chloroquine in a concentration
of 0.25 mg/kg; Groups 7 and 8 were given chow
containing 0.5 mg/kg 8-methoxypsoralen; and
Groups 9 and 10 were fed chow containing 0.25
mg/kg of Triquin. After about 9 months (Decem-
ber 31, 1959) when the mice had received 10,100
r an evaluation was carried out independently
by two observers (Drs. Knox and Shapiro) and
it was decided to increase the irradiation given
to half the mice in each category; consequently,
on January 2, 1960, the dosage given Groups 3, 5,
7, and 9 was increased to 100 r daily, and Groups
4, 6, 8, and 10 continued to receive the original
dose of 50 r daily.
On June 4, 1960, the mice were again evaluated
independently by the same two observers and at
this time Groups 3, 5, 7, and 9 had received a
total dose of 22,300 r and Groups 4, 6, 8, and 10
had received 16,200 r. It was then decided to
continue irradiation until the above-named groups
had received 30,000 r and 20,000 r respectively.
Following administration of these total dosages of
irradiation the mice were maintained in wire
cages, fed laboratory chow and water ad libitum
and observed carefully for an additional one-year
period.
Animals which died during the course of this
experiment were autopsied and the tissues pre-
served in 10% formalin for histopathologic study.
In addition, some animals which developed tumors
were killed and autopsied to prevent the possible
loss of study material. In some cases the animals
died during the night and because of autolysis or
cannibalism among the mice satisfactory speci-
mens were not obtained. The formalin-fixed
tissue was embedded in paraffin, sectioned, and
stained with hematoxylin and eosin in a routine
manner.
EE5ULT5
When viewed daily during the first few months
of treatment, interesting transitory periods of
erythema of the ears were observed in some of the
mice at approximately 7 to 10 day intervals.
There was considerable individual variation in
response for the ears of some of the mice appeared
to be pinker than others. This was interpreted as
an erythema dose effect which would be analogous
to the crythema dose of conventional x-ray.
Unirradiated control animals showed no cry-
FIG. 1. A grenz-irradiated mouse manifesting
diffuse hair loss and several ulcerated crusted
squamous cell carcinomas.
FIG. 2. This mouse received Triquin and grenz
ray irradiation. A solitary squamous cell car-
cinoma is seen along with moderate hair loss on
the neck and shoulders.
thema. In all eases the changes were transient
and did not persist. There was very little destruc-
tion of tissue in the ears of any of the mice.
A. Evaluation of Gross Changes
In December, 1959, after 9 months of irradia-
tion (10,000 r) the absolute control groups (no
drugs and no radiation) did not show any
changes. The coats were sleek and the mice
appeared healthy and well fed, and these animals
remained in good condition throughout the
remainder of the experiment. In Groups 3 and 4
(the irradiated controls) a majority of the mice
showed increased vascularization of the ears with
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FIG. 3. A low power view of the tumor shown in Fig. No. 2 showing a thick crust and invasion of
subcutis. (Magnif. 11 X)
FIG. 4. A high power view of the margin of the tumor presented in Figs. 2 and 3 showing invasive neo-
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slight necrosis at the lateral margins of the cars.
This was more evident in Group No. 4 than in
Group No. 3. One mouse in Group No. 4 devel-
oped a large subcutaneous tumor on the hack of
the neck and was sacrificed for histologic study.
The tumor was identified as a breast tumor. The
mice receiving ehloroquine and irradiation
(Groups 5 and 6) were indistinguishable from
those in the absolute control groups. The methox-
salen fed mice (Groups 7 and 8) showed slight
dilatation of the ear vessels. These changes were
not as marked as in Groups 3 and 4; however,
there was definite erythema of these ears when
compared to the absolute control animals. The
Triquin fed groups (Nos. 9 and 10) were also
indistinguishable from the unirradiated control
groups.
At a later evaluation in June, 1960, 14 months
after the experiment was begun, the following
observations were made. In Group No. 3 (100 r
daily) the ears showed increased vaseularization
when compared to controls and these ears were
slightly ragged on the edges. Also, the fur on 3
mice appeared slightly ruffled. One mouse had a
small raised verrueous crusted skin lesion which
was very suggestive of a squamous cell carci-
noma and a smaller tumor on another mouse was
similar. In Group No. 4 which had continued to
receive 50 r of grenz ray per day, one mouse had
a large tumor on the back which was ulcerated
and covered with a dark crust. This mouse was
smaller and appeared weaker than the other
mice in this group. The tumor was later shown
to be a breast tumor. The ears were more ragged
and telangiectatie and were definitely pinker
than the non-irradiated control groups.
In Group No. 5 (100 r per day plus ebloro-
quine) two of six survivors had ruffled fur and
the ears on all six mice were still essentially in-
distinguishable from the non-irradiated animals.
In Group No. 6 (50 r per day plus ehloroquine)
one mouse had ruffled fur and another had a
small cutaneous mass having the appearance of a
breast tumor but the ears of these two mice and
the others in this group were indistinguishable
from those of the absolute control mice. In Group
No. 7 (100 r per day plus methoxsalen) the ears
of seven survivors were very slightly telangiec-
tatic but not as pink as in Groups 3 or 4. In Group
No. 8 (50 r per day and 8-MP in the diet) the
ears of seven survivors were slightly telangiec-
tatie as were those in Group No. 7. In Group No.
9 (100 r per day plus Triquin) the ears were no
different in appearance from the absolute control
mice; however, one mouse had scratched both
sides of the neck until it was ulcerated and its
ears were folded. Several of these mice bad
slightly ruffled fur. Group No. 10 (50 r per
day plus Triquin) included one mouse which had
a large subcutaneous tumor on the back which
was probably of breast origin. Most of the mice
in this cage appeared sleek and well fed and their
ears were similar in appearance to those of the
absolute control animals.
As noted above, several of the mice had large
tumors on the back and shoulders which were not
attached to the skin. On histologic examination
these tumors were shown to be breast tumors
which had no direct anatomical continuity with
the skin. The development of these breast tumors
was sporadic throughout the course of the experi-
ment and occurred in controls as well as treated
groups; therefore, this phenomenon was con-
sidered to be an individual strain susceptibility
rather than being due to any effect of the grenz
ray treatment.
The experiment was arbitrarily terminated
June 1, 1961, approximately two years after the
start of the experiment although a few surviving
animals are still under observation. At this time
seven of the twenty absolute control animals
were still living and none had developed squa-
mous cell carcinomas of the skin. Only one or
two survivors remained in each of the test groups
except Group No. 6 which had no survivors. How-
ever, more of the test animals were sacrificed for
study of their tumors and this factor would likely
alter the significance of observations on longevity.
Six of 40 mice survived in the group which re-
ceived 30,000 r, and five of 40 in the groups
which had been given 20,000 r.
In addition to the tumor formation, the animals
in the test groups demonstrated progressive hair
loss on the dorsum of the back and face. (Chart
No. 1). This was most noticeable in the animals
receiving 30,000 r and was seen in the animals
receiving ehloroquine and Triquin as well as the
groups receiving grenz ray alone. The animals
receiving 20,000 r showed only slight hair loss
which was never as severe as that found in mice
receiving the larger dosage of 30,000 r. Hair loss
was not recorded in the psoralen treated groups;
however, there were no survivors during the
latter course of the experiment among the
psoralen fed animals which received 30,000 r.
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Total No. With
Group Treatment Squamous Cell Presence of
No. Received Carcinomas Hair Loss
1 Control 0 ——
2 Control 0 — —
4 20,000 r — No drug 0 +
6 20,000 r — Chioroquine 0 +
8 20,000r—8-MP 0 ——
10 20,000 r — Triquin 0 +
3 30,000 r — No drug 3 + +
5 30,000 r — Chioroquine 2 ÷ +
7 30,000r—8-MP 0 ?
9 30,000 r — Triquin 4 + +
Total 9
CHART NO. 1
APPROXIMATE TIME OF APPEARANCE OF SQUANOUS CELL CARCINOMA
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B. Carcinogenesis
Fourteen months after the initiation of the
experiment a few animals in the test groups
receiving grenz ray developed what appeared to
be small squamous cell carcinomas of the skin of
the back. At this time they had received 22,300 r.
These lesions were allowed to continue to grow
after completion of the course of grenz ray irradi-
ation. The tumors first appeared as small dark
round crusted lesions which later enlarged into
elevated tumor masses up to 1—2 cm. in diameter.
They were covered by a thick horny crust. As
these tumors became well developed some of the
animals were killed and autopsied to be certain
that the lesions could be examined histologically.
In all instances the skin tumors were squamous
carcinomas. They showed a tendency to excessive
keratinization, acanthosis and malignant dys-
keratosis. Also, mitotic figures, keratin pearls,
individual cell keratinization, and variation in
size and shape of nuclei were constant findings.
These lesions invaded the underlying dermis,
occasionally even into muscle layers. No metas-
tases were seen in any of the animals autopsied.
The tumors were often multiple and occurred on
the back and face, and in one instance on an ear.
From Chart No. 1 it can be seen that squamous
cell carcinomas occurred only in the groups
receiving a total dose of 30,000 r of grenz ray.
The first tumors appeared after the animals had
received 22,300 r. No squamous carcinomas were
seen in the absolute controls or in the mice re-
ceiving 20,000 r. Also, tumors did not develop
in the mice fed 8-MP; however, there were few
long-term survivors in the 8-MP group receiving
30,000 r. Chart No. 2 shows the cumulative
totals of tumors produced and the approximate
time of their appearance. Of nine animals which
developed one or more squamous cell carcinomas,
three had received grenz ray alone, two had been
fed chloroquine and irradiated, and four were in
the Triquin group.
DIscUssIoN
The amount of grenz radiation which the
mice received appeared to have caused remark-
ably little evidence of general biologic effect on
the mice. While more of the control animals lived
longer than in the irradiated groups, this finding
is of uncertain significance and suggests the need
for further careful study of the effects of grenz
ray on longevity of mice. The mice which received
the greater dosage of 30,000 r showed no signifi-
cant difference in survival from those with only
20,000 r.
The most striking changes other than squa-
mous cell carcinomas were the hair loss and
thickening of the ear margins. Autopsies failed
to demonstrate any definite visceral alterations
which could be attributed to the drugs or the
irradiation. The mice continued to develop
tumors throughout the period of observation
following completion of grenz ray exposure;
therefore, grenz rays appear to be similar to
x-rays in yielding a post-irradiation carcinogenic
effect. Most of the tumors formed were on the
back, face, or neck and only one formed on an
ear, the site of predilection for ultraviolet induced
tumors in albino mice. This difference is most
likely due to the protective effect of the hair
against ultraviolet damage and lack of protection
against the effects of grenz ray. All other tumors
which developed were of breast origin of a type
which apparently occurs spontaneously in this
strain of mice. The skin tumors which developed
were all squamous cell carcinomas, and it is most
likely that irradiation induced these tumors
through some biologic effect. The early erythema-
tous changes which were noticed in the ears did
not persist or progress into the scarred con-
tracted ears seen after prolonged ultraviolet
light exposure.
Initially the impression was gained that the
drugs, particularly chloroquine and Triquin,
offered some protection for the ears against grenz
ray induced changes; however, at the end of the
irradiation period the ears of all mice were essen-
tially indistinguishable from those of the irradi-
ated controls.
Since squamous cell carcinoma is not a spon-
taneously occurring tumor in this strain of mice,
and since no lesions of this type developed in any
of the control animals, it would seem that the
squamous cell carcinomas which developed can
be attributable to the grenz rays which the mice
received.
5UMMARY
1. One hundred albino mice were divided into
groups and exposed to grenz ray in low dosage
(50 to 100 r/day) over a prolonged period of time
giving a total dosage of 20,000 or 30,000 r.
Following irradiation they were kept under
observation for a period of one year with no
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conclusive differences in longevity of the various
groups.
2. The antimalarial drugs, Triquin and ehloro-
quine, which initially appeared to offer some
protection to the skin of the ears did not prevent
the development of squamous cell carcinomas.
3. Squamous cell carcinomas were produced in
mice receiving a total dose of 30,000 r of grenz
ray but not in those receiving only 20,000 r.
4. Additional changes consisting of dorsal hair
loss and telangieetasia plus slight thickening of
ear margins were noted in all irradiated animals
but these changes were less severe in the groups
receiving only 20,000 r.
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DISCUSSION
DR. MARK B. HOLLANDEE (Baltimore, Mary-
land): I think the authors have done a beauti-
fully detailed and carefully studied piece of work
which shows the result of careful planning.
In so thin-skinned a test animal as the mouse,
the quality of grenz ray that was used becomes
of critical importance; and I think that it would
be helpful if we knew the precise half value layer
and the exciting voltage that were used. That
temporary hair loss was seen is not surprising.
This has been reported before, and is entirely a
depth dose effect.
The absence of deeper sequelae is, of course, no
surprise, for exactly the same reason; grenz rays
of any quality penetrate to so limited an extent
that one would not expect material deep damage.
In these tiny animals, the harder qualities of
grenz rays have been reported to affect the
growth centers in bone (Jochims, J. & Kolrep,
M.: tiber Gefahren der tiberdosierung mit
Grenzstrahlen beim waehsenden Organismus,
Deutsche med. Wehnsehr. 58: 1047, 1932), and,
though it has not been reported, damage to bone
marrow should be equally possible.
BR. FAEBINGTON DANIELS, JR. (Portland,
Oregon): I am glad the authors confined their
conclusions at the end to the fact that these
changes can be produced. I was afraid for a while
that they might be trying to draw conclusions on
the relative protection or nonproteetion of these
various agents.
From the statistical standpoint, I would
certainly feel happier if they had had larger
samples of each variable and a smaller number of
variables to prove some of these differences. I
don't think you can say on the evidence presented
that the drugs either do or do not have a protec-
tive effect.
DR. VICToR H. WITTRN (New York, New
York): A service has been rendered by the
authors through their calling to our attention the
large number of roentgens required to produce
radiation changes in the skin of the guinea-pig.
Br. Hollander is quite correct in considering
the thickness of these tissues; we have yet to
learn at what sites (depth) within tissue ionizing
radiation must act in order to produce carcinoma.
There may be quite a difference in this regard
between animal and man.
It is very important to realize (and I say this
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because of the current fear in the minds of some
concerning the use of ionizing radiation in the
treatment of dermatoses) that one cannot use
the experimental animal as a means for deciding
on the safety or the harm that may be caused by
a particular type of radiation. After all, in labora-
tory animals it is possible with ultraviolet radia-
tion, tar and other agents to produce carcinoma
of their skin; similarly it does not come as a
surprise that grenz rays might also do so.
The clinical experience in man with grenz
radiation over many years and in large total
doses attests to the safety of this form of radia-
tion for therapeutic uses; doses as high as 10,000
and 15,000 roentgens have been given to a single
area over periods of from five to ten years without
causing carcinoma or other undesirable sequellae.
I am sure that all of us would have liked to see
a comparison of the number of roentgens of
conventional x-ray required to produce carci-
noma in the guinea pig as compared to the grenz
rays. (Dr. Knox proposes such a study for the
future, I believe.) It would be preferable, of
course, to have man as the experimental animal,
where the safety of grenz radiation is assured
when properly used.
Dn. JOHN EPSTEIN (San Francisco, California):
Along with what Dr. Witten was saying, I think
where the rays are significant, we do frequently
produce with ultraviolet light sarcomas in the
dermis of the mouse, the epidermis being very
thin and hence not shielding the dermis from the
more toxic rays.
The question I would like to ask is, were there
any histologic skin changes in the autopsied
mice that did not have tumors?
DR. ROBERT STOLAR (Washington, D. C.):
I wish to make a point of one difference that I
found in treating a scalp experimentally. I had
two patients with mycosis fungoides and desired
to see how much grenz ray it would take to
depilate a portion of the scalp.
I measured off areas on the scalp, gave up to
30,000 roentgens at 26 microns of aluminum
half-value layer in a cumulative series of treat-
ments and didn't produce any depilation.
I support Dr. Hollander's remarks that there
certainly are variations between the mouse and
human skin in relation to depth of appendages,
thickness of dermis or other factors which will
create a difference of response modified by
variations of the half value layer dosage delivered.
DE. EDWARD M. SHAPIRO (in closing): In
answer to Dr. Hollander, the grenz ray was
given with a Universal Grenz Ray Treat-Master
machine half-value layer of .025 millimeters of
aluminum, 12 kv and 10 milliamp. Fifty r were
delivered in approximately 13 seconds.
In answer to Dr. Daniels, the drugs which we
used were those which primarily offered protec-
tion against ultraviolet light. We did not feel
that any of them offered protection against
grenz ray. Even though we did not get any
carcinomas in the 8-methoxypsoralen group, we
still do not feel that we have sufficient evidence
to say this drug does protect against the effects
of the ray.
In answer to Dr. Witten, I would like to do
the same thing that Dr. Daniels did yesterday;
I would like to paraphrase Dr. Pinkus' in saying
that "Mice are not men".
